Cynthia MacKenzie-Balnius, RN, BSN

University of ChicagoChicago, Illinois - 60637 |
- CLINICAL TRIALS 1
- CONDITIONS4
- INTERVENTIONS1
- SINCE2008

A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas
April 2008 - March 2017
Neurofibroma
Neurofibromatoses
Neurofibroma, Plexiform
Neurofibromatosis 1
Sirolimus, Rapamycin



